Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshida Konoe-cho, Kyoto, Japan.
Fujiidera Keijinkai Clinic, Fujiidera, Japan.
Am J Nephrol. 2018;48(2):87-95. doi: 10.1159/000492034. Epub 2018 Aug 7.
Although some clinical practice guidelines regarding hemodialysis recommend salt restriction, few studies have examined the association between salt intake and clinical outcomes in hemodialysis patients. This study aimed to clarify the association between salt intake and mortality in hemodialysis patients.
This retrospective cohort study was based on the Japanese Society for Dialysis Therapy renal data registry database (2008) and included 88,115 adult patients who had received hemodialysis for at least 2 years. Estimated salt intake was the main predictor and was calculated from intra-dialytic weight loss and pre- and post-dialysis serum sodium levels. Nonlinear logistic regression was used to determine the association between salt intake and mortality, adjusting for potential confounders. The outcomes considered were all-cause mortality and cardiovascular death at 1 year.
The median (25-75th percentile) salt intake at baseline was 6.4 (4.6-8.3) g/day. At 1 year, all-cause mortality occurred in 1,845 (2.1%) patients, including 807 cardiovascular deaths. The low salt intake group (< 6 g/day) demonstrated the highest all-cause mortality and cardiovascular deaths. No association was observed between high salt intake, all-cause mortality and cardiovascular deaths. The lowest risk for all-cause mortality and cardiovascular death occurred among patients with an estimated salt intake of 9 g/day.
Low salt intake, but not high salt intake, was associated with all-cause and cardiovascular mortality in Japanese hemodialysis patients. Further studies to justify including a lower limit of salt intake for hemodialysis patients are suggested.
尽管一些关于血液透析的临床实践指南建议限制盐的摄入,但很少有研究探讨血液透析患者的盐摄入量与临床结局之间的关系。本研究旨在阐明血液透析患者盐摄入量与死亡率之间的关系。
这是一项基于日本透析治疗学会肾脏数据注册数据库(2008 年)的回顾性队列研究,纳入了 88115 名至少接受过 2 年血液透析治疗的成年患者。估计盐摄入量是主要预测指标,由透析期间体重减轻和透析前后血清钠水平计算得出。采用非线性逻辑回归调整潜在混杂因素后,分析盐摄入量与死亡率之间的关系。考虑的结局包括 1 年时的全因死亡率和心血管死亡。
基线时(25-75 分位)盐摄入量的中位数(四分位距)为 6.4(4.6-8.3)g/天。1 年内,1845 例(2.1%)患者发生全因死亡,其中 807 例为心血管死亡。低盐摄入组(<6 g/天)的全因死亡率和心血管死亡率最高。高盐摄入与全因死亡率和心血管死亡率之间无相关性。估计盐摄入量为 9 g/天时,全因死亡率和心血管死亡率最低。
在日本血液透析患者中,低盐摄入而非高盐摄入与全因死亡和心血管死亡相关。建议进一步研究确定血液透析患者盐摄入量的下限。